Delivery Order SPE2DB22D2206-SPE2DB24FJF03
Award Date
7/15/24
Potential Completion Date
7/16/24
Potential Value
$4.6K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $7,653.80 firm fixed-price delivery order has a completion date of June 20, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive range of pharmaceutical products and medical supplies to DLA...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of the pharmaceutical product "MONOVISC 88 MG/4 ML SYRINGE 4ML" to the Defense Logistics Agency (DLA). The $4,647.12 firm fixed-price delivery order has an ultimate completion date of April 30, 2024. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to deliver...
This federal contract award to Amerisourcebergen Drug Corporation's Corporate Office Division is for the delivery of MONOVISC 88 MG/4 ML syringes. The $4,647.12 firm fixed price delivery order was awarded by the Defense Logistics Agency (DLA), a defense agency within the Department of Defense, on May 30, 2024 with a completion date of May 31, 2024. The contract has no set-aside designation. Amerisourcebergen, one of the largest pharmaceutical distribution companies in the world, holds a...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $4,647.12 for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract, which has a completion date of June 28, 2024, was awarded by the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen, a major pharmaceutical distribution company,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of a pharmaceutical product called MONOVISC 88 MG/4 ML SYRINGE 4ML. The $4,647.12 firm fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics, acquisition, and technical services to the U.S. Armed Forces and other government agencies. Amerisourcebergen, a major pharmaceutical distribution company, holds a...
The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract worth $4,647.12 to Amerisourcebergen Drug Corporation's Corporate Office Division. The contract is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, with a period of performance through May 31, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025....
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,054.01 firm fixed-price delivery order was awarded to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc. The contract has an ultimate completion date of May 3, 2024. AmerisourceBergen Drug Corp holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,995.64 Firm Fixed Price Delivery Order is for the supply of MONOVISC 88 MG/4 ML SYRINGE 4ML, a medical product. The contract has an ultimate completion date of December 6, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award is for the delivery of MONOVISC 88 MG/4 ML SYRINGE 4ML medical supplies to the Defense Logistics Agency (DLA). The $17,414.44 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of May 14, 2024 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
The U.S. government awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a for-profit subsidiary of Amerisourcebergen Corporation, to provide a pharmaceutical product called MONOVISC 88 MG/4 ML SYRINGE 4ML. The contract, valued at $11,771.65, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on March 21, 2024 with an ultimate completion date of March 22, 2024. This delivery order contract is part of a larger indefinite delivery contract (IDC)...